Nuwellis logo

Nuwellis Share Price Today

(NASDAQ: NUWE)

Nuwellis share price is $1.25 & ₹108.71 as on 6 Mar 2025, 2.30 'hrs' IST

$1.25

0.02

(1.63%)

Market is closed - opens 8 PM, 06 Mar 2025

View live Nuwellis share price in Dollar and Rupees. Guide to invest in Nuwellis stock from India, including Indian investor sentiment. Get details on Indian mutual funds investing in Nuwellis, along with analyst recommendations, forecasts, and comprehensive financials.

Nuwellis share price movements

  • Today's Low: $1.22
    Today's High: $1.27

    Day's Volatility :3.56%

  • 52 Weeks Low: $0.92
    52 Weeks High: $18.01

    52 Weeks Volatility :94.87%

Nuwellis (NUWE) Returns

PeriodNuwellis IncIndex (Russel 2000)
3 Months
0.0%
0.0%
6 Months
18.3%
0.0%
1 Year
-92.45%
0.0%
3 Years
-99.96%
-11.6%

Nuwellis (NUWE) Key Statistics

in dollars & INR

Previous Close
$1.23
Open
$1.26
Today's High
$1.265
Today's Low
$1.22
Market Capitalization
$5.4M
Today's Volume
$78.8K
52 Week High
$18.011
52 Week Low
$0.9237
Revenue TTM
$9.0M
EBITDA
$-11.9M
Earnings Per Share (EPS)
$-62.29
Profit Margin
-169.54%
Quarterly Earnings Growth YOY
0.0%
Return On Equity TTM
-276.02%

How to invest in Nuwellis Stock (NUWE) from India?

It is very easy for Indian residents to invest directly in Nuwellis from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the Nuwellis stock in both Indian Rupees (INR) and US Dollars (USD). Search for Nuwellis or NUWE on the INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of Nuwellis or rupee/ dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of Nuwellis shares which would translate to 0.696 fractional shares of Nuwellis as of today. Learn more about fractional investing.

Indians can now also easily transfer and add money to their US stocks account via the INDmoney app. Invest in US Stocks from India, including recognised companies like Nuwellis, in just a few clicks!

Returns in Nuwellis (NUWE) for Indian investors in Rupees

The Nuwellis stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

  • 10Y

Nuwellis investment value today

Current value as on today

₹12,502

Returns

₹87,498

(-87.5%)

Returns from Nuwellis Stock

₹92,447 (-92.45%)

Dollar Returns

₹4,949 (+4.95%)

Indian investors sentiment towards Nuwellis (NUWE)

-79%

Period: Feb 3, 2025 to Mar 5, 2025. Change in 30 Days versus previous period

Search interest for Nuwellis Stock from India on INDmoney has decreased by -79% in the last 30 days, reflecting a downward trend in search activity.

Global Institutional Holdings in Nuwellis

  • Geode Capital Management, LLC

    0.70%

  • UBS Group AG

    0.53%

  • Citadel Advisors Llc

    0.27%

  • TWO SIGMA SECURITIES, LLC

    0.26%

  • Tower Research Capital LLC

    0.11%

  • SBI Securities Co Ltd

    0.01%

Analyst Recommendation on Nuwellis

Buy

    75%Buy

    25%Hold

    0%Sell

Based on 8 Wall street analysts offering stock ratings for Nuwellis(by analysts ranked 0 to 5 stars)

Based on 8 analyst
  • Current
  • 1M Ago
  • 3M Ago
Buy
6
7
7
Hold
2
2
2
Sell
0
0
0

Analyst Forecast on Nuwellis Stock (NUWE)

What analysts predicted

Upside of 1180.0%

Target:

$16.00

Current:

$1.25

Insights on Nuwellis Stock (Ticker Symbol: NUWE)

  • Price Movement

    In the last 1 year, NUWE stock has moved down by -92.4%
  • Increasing Revenue

    Revenue is up for the last 3 quarters, 1.85M → 2.36M (in $), with an average increase of 11.3% per quarter
  • Increasing Net Profit

    Netprofit is up for the last 2 quarters, -7.72M → 2.35M (in $), with an average increase of 427.6% per quarter
  • NUWE vs BSX (1 yr)

    In the last 1 year, Boston Scientific Corp. has given 55.3% return, outperforming this stock by 147.7%
  • NUWE vs BSX (3 yr)

    In the last 3 years, Boston Scientific Corp. has given 138.2% return, outperforming this stock by 238.2%
  • Price to Sales

    ForNUWE every $1 of sales, investors are willing to pay $0.1, whereas for Boston Scientific Corp., the investors are paying $9.2 for every $1 of sales.

NUWE Nuwellis Financials in INR & Dollars

FY18Y/Y Change
Revenue
$5.0M
↑ 40.67%
Net Income
$-17.0M
↑ 27.28%
Net Profit Margin
-340.78%
↑ 35.86%
FY19Y/Y Change
Revenue
$5.5M
↑ 10.26%
Net Income
$-18.1M
↑ 6.35%
Net Profit Margin
-328.69%
↑ 12.09%
FY20Y/Y Change
Revenue
$7.4M
↑ 35.02%
Net Income
$-15.8M
↓ 12.58%
Net Profit Margin
-212.82%
↑ 115.87%
FY21Y/Y Change
Revenue
$7.9M
↑ 6.45%
Net Income
$-19.6M
↑ 23.63%
Net Profit Margin
-247.17%
↓ 34.35%
FY22Y/Y Change
Revenue
$8.5M
↑ 7.85%
Net Income
$-14.5M
↓ 25.81%
Net Profit Margin
-170.02%
↑ 77.15%
FY23Y/Y Change
Revenue
$8.9M
↑ 3.76%
Net Income
$-20.2M
↑ 39.13%
Net Profit Margin
-227.99%
↓ 57.97%
Q2 FY23Q/Q Change
Revenue
$2.1M
↑ 13.64%
Net Income
$-4.8M
↓ 25.29%
Net Profit Margin
-233.49%
↑ 121.66%
Q3 FY23Q/Q Change
Revenue
$2.4M
↑ 16.24%
Net Income
$-3.4M
↓ 30.44%
Net Profit Margin
-139.72%
↑ 93.77%
Q4 FY23Q/Q Change
Revenue
$2.6M
↑ 5.76%
Net Income
$-5.5M
↑ 63.47%
Net Profit Margin
-215.95%
↓ 76.23%
Q1 FY24Q/Q Change
Revenue
$1.9M
↓ 27.21%
Net Income
$-3.8M
↓ 31.22%
Net Profit Margin
-204.04%
↑ 11.91%
Q2 FY24Q/Q Change
Revenue
$2.2M
↑ 18.15%
Net Income
$-7.7M
↑ 103.88%
Net Profit Margin
-352.1%
↓ 148.06%
Q3 FY24Q/Q Change
Revenue
$2.4M
↑ 7.89%
Net Income
$2.4M
↓ 130.52%
Net Profit Margin
99.62%
↑ 451.72%
FY18Y/Y Change
Profit
$1.3M
↑ 68.1%
FY19Y/Y Change
Profit
$2.9M
↑ 114.68%
FY20Y/Y Change
Profit
$4.1M
↑ 42.3%
FY21Y/Y Change
Profit
$4.5M
↑ 10.7%
FY22Y/Y Change
Profit
$4.8M
↑ 5.88%
FY23Y/Y Change
Profit
$5.0M
↑ 4.79%
Q2 FY23Q/Q Change
Profit
$1.1M
↑ 7.5%
Q3 FY23Q/Q Change
Profit
$1.4M
↑ 20.4%
Q4 FY23Q/Q Change
Profit
$1.4M
↑ 0.51%
Q1 FY24Q/Q Change
Profit
$1.2M
↓ 14.19%
Q2 FY24Q/Q Change
Profit
$1.5M
↑ 23.76%
Q3 FY24Q/Q Change
Profit
$1.7M
↑ 12.35%
FY18Y/Y Change
Operating Cash Flow
$-14.6M
↑ 22.15%
Investing Cash Flow
$-198.0K
↓ 23.55%
Financing Cash Flow
$4.6M
↓ 82.43%
FY19Y/Y Change
Operating Cash Flow
$-16.4M
↑ 12.41%
Investing Cash Flow
$-490.0K
↑ 147.47%
Financing Cash Flow
$12.7M
↑ 172.54%
FY20Y/Y Change
Operating Cash Flow
$-16.6M
↑ 1.25%
Investing Cash Flow
$-267.0K
↓ 45.51%
Financing Cash Flow
$30.0M
↑ 137.0%
FY21Y/Y Change
Operating Cash Flow
$-17.9M
↑ 7.89%
Investing Cash Flow
$-219.0K
↓ 17.98%
Financing Cash Flow
$27.9M
↓ 7.15%
FY22Y/Y Change
Operating Cash Flow
$-15.1M
↓ 15.27%
Investing Cash Flow
$14.7M
↓ 6825.11%
Financing Cash Flow
$9.4M
↓ 66.19%
Q2 FY23Q/Q Change
Operating Cash Flow
$-5.3M
↓ 13.99%
Investing Cash Flow
$513.0K
↑ 0.0%
Financing Cash Flow
$2.1M
↓ 19363.64%

Nuwellis Technicals Summary

Sell

Neutral

Buy

Nuwellis is currently in a neutral trading position according to technical analysis indicators.

Nuwellis (NUWE) Vs Peers

Company Name1 Month6 Month1 Year3 Years5 Years
Nuwellis Inc logo
1.63%
18.3%
-92.45%
-99.96%
-99.99%
Medtronic Plc logo
3.4%
5.22%
9.95%
-11.8%
1.8%
Edwards Lifesciences Corp. logo
2.13%
10.35%
-17.53%
-32.76%
14.39%
Boston Scientific Corp. logo
1.13%
28.68%
55.31%
146.09%
207.16%
Stryker Corporation logo
0.84%
10.53%
11.46%
56.15%
129.21%
Abbott Laboratories logo
6.67%
21.76%
15.39%
15.86%
78.8%
Company NameP/E RatioP/B RatioPEG RatioEPSROEROADiv YieldBVPS
Nuwellis Inc logo
0.02
NA
NA
0.0
-2.76
-0.84
NA
1.7
Medtronic Plc logo
28.71
28.71
1.91
5.45
0.08
0.05
0.03
38.49
Edwards Lifesciences Corp. logo
31.13
31.13
5.57
2.45
0.17
0.08
NA
16.99
Boston Scientific Corp. logo
84.24
84.24
1.87
2.86
0.09
0.05
NA
14.76
Stryker Corporation logo
50.77
50.77
2.91
13.49
0.15
0.07
0.01
54.1
Abbott Laboratories logo
18.34
18.34
2.52
5.15
0.31
0.06
0.02
27.52
Company NameAnalyst ViewMarket Cap5 Years Return %PE RatioProfit Margin
Nuwellis Inc logo
Buy
$5.4M
-99.99%
0.02
-169.54%
Medtronic Plc logo
Buy
$119.3B
1.8%
28.71
12.83%
Edwards Lifesciences Corp. logo
Buy
$42.8B
14.39%
31.13
76.75%
Boston Scientific Corp. logo
Buy
$152.9B
207.16%
84.24
11.07%
Stryker Corporation logo
Buy
$148.8B
129.21%
50.77
13.25%
Abbott Laboratories logo
Buy
$238.6B
78.8%
18.34
31.95%

About Nuwellis

Nuwellis, Inc., a medical device company, develops, manufactures, and commercializes medical devices used in ultrafiltration therapy. The company offers Aquadex FlexFlow and Aquadex SmartFlow systems, which are used to treat patients suffering from fluid overload due to heart failure. Its Aquadex FlexFlow system includes a console, disposable blood circuit set, and disposable catheter. The company sells its products to hospitals and clinics through its direct salesforce in the United States; and through independent specialty distributors in Austria, Belarus, Brazil, Colombia, the Czech Republic, Germany, Greece, Hong Kong, India, Israel, Italy, Panama, Romania, Singapore, Slovakia, Spain, Switzerland, Thailand, the United Arab Emirates, and the United Kingdom. The company was formerly known as CHF Solutions, Inc. and changed its name to Nuwellis, Inc. in April 2021. Nuwellis, Inc. was founded in 1999 and is headquartered in Eden Prairie, Minnesota.
Organization
Nuwellis
Employees
59
CEO
Mr. John L. Erb
Industry
Miscellaneous

Management People of Nuwellis

NameTitle
Mr. John L. Erb
Interim President, Interim CEO & Chairman of the Board
Mr. Robert B. Scott
Chief Financial Officer
Mr. Neil P. Ayotte Esq.
Senior VP, General Counsel, Secretary & Chief Compliance Officer
Betsy Riemenschneider
Vice President of Sales
Ms. Sandra Eayrs
Chief Human Resources Officer
Dr. John Lynn Jefferies FACC, M.B.A., M.D., M.P.H.
Chief Medical Officer & Member of Medical Advisory Board
Mr. Paul Wotta
Corporate Controller

Important FAQs about investing in NUWE Stock from India :

What is Nuwellis share price today?

Nuwellis share price today stands at $1.25, Open: $1.26 ; Previous Close: $1.23 ; High: $1.27 ; Low: $1.22 ; 52 Week High: $18.01 ; 52 Week Low: $0.92.

The stock opens at $1.26, after a previous close of $1.23. The stock reached a daily high of $1.27 and a low of $1.22, with a 52-week high of $18.01 and a 52-week low of $0.92.

Can Indians buy Nuwellis shares?

Yes, Indians can invest in the Nuwellis (NUWE) from India.

With INDmoney, you can buy Nuwellis at 0 brokerage. The step-by-step process is as follows:

  • Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
  • Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
  • Once funds are transferred successfully, you can buy Nuwellis at zero transaction cost.

How can I buy Nuwellis shares from India?

It is very easy to buy Nuwellis from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of Nuwellis (NUWE) be purchased?

Yes, you can buy fractional shares of Nuwellis with INDmoney app.

What are the documents required to start investing in Nuwellis stocks?

To start investing in Nuwellis, You will need the following documents:

  • Proof of Identification (PAN, Aadhaar etc)
  • Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.

What are today’s High and Low prices of Nuwellis Stock (NUWE)?

Today’s highest price of Nuwellis (NUWE) is $1.27.

Today’s lowest price of Nuwellis (NUWE) is $1.22.

What is today's market capitalisation of Nuwellis?

Today's market capitalisation of Nuwellis NUWE is 5.4M

What is the 52 Week High and Low Range of Nuwellis Stock (NUWE)?

  • 52 Week High

    $18.01

  • 52 Week Low

    $0.92

What are the historical returns of Nuwellis (NUWE)?

  • 1 Month Returns

    1.63%

  • 3 Months Returns

    18.3%

  • 1 Year Returns

    -92.45%

  • 5 Years Returns

    -99.99%

Who is the Chief Executive Officer (CEO) of Nuwellis ?

Mr. John L. Erb is the current Chief Executive Officer (CEO) of Nuwellis.